Neurology CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
Examining Late-Breaking Data on Disease-Modifying Therapies for the Treatment of Multiple Sclerosis — An Update From Philadelphia
Bruce Cree, MD, PhD, MAS
15 July, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Clinical Pearls for the Accurate Diagnosis and Optimal Treatment of Hereditary ATTR Amyloidosis
Michael Polydefkis, MD
11 July, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers
2 July, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progressive Supranuclear Palsy: Examining Diagnostic Considerations and Emerging Treatment Approaches
Adam Boxer, MD
17 June, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints
Jerry Vockley, MD, PhD
30 May, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Exploring Unmet Needs in Large Hemispheric Infarction: Clinical Insights on Early Recognition and Emerging Therapy
Kevin N. Sheth, MD
29 May, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Harnessing the Full Potential of Available Therapies for the Treatment of Lennox-Gastaut Syndrome: A Story Behind the Science
Anup Patel, MD, FAAN
29 March, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection
Aaron Boster, MD
4 March, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
Richard Finn, MD
15 February, 2019
Credits: 0.75 CME
Medical Learning Institute, Inc.
Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
Marwan Sabbagh, MD, FAAN
30 January, 2019
Credits: 0.50 CME
Penn State College of Medicine
Breaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden
Richard Finkel, MD
28 December, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
Barry Singer, MD
21 December, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era
Steven Brem, MD
17 December, 2018
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options
Joseph McEvoy, MD
13 December, 2018
Credits: 1.25 CME
Medical Learning Institute, Inc.
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
Stewart Tepper, MD, FAHS
3 December, 2018
Credits: 1.00 CME
Penn State College of Medicine
Improving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?
Deborah Friedman, MD, MPH
23 November, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
Loren del Mar Pena, MD, PhD
8 November, 2018
Credits: 0.50 CME
Penn State College of Medicine
Assessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis
Hiroshi Mitsumoto, MD, DSc
18 October, 2018